Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Final Diagnoses and Diagnostic Error in Pediatric Patients with Presumed Papilledema
Neuro-ophthalmology/Neuro-otology
Neuro-ophthalmology/Neuro-otology Posters (7:00 AM-5:00 PM)
006

Papilledema in the pediatric population is seen as part of idiopathic intracranial hypertension (IIH), but can also be a sign of significant pathology. We investigate the final diagnoses in pediatric patients referred for suspected IIH to characterize findings that may indicate an alternate diagnosis.

To categorize alternate diagnoses and diagnostic error in pediatric patients initially referred for suspected IIH.

All pediatric patients referred for suspected IIH from 2008-2018 were identified. Patients with known structural etiologies were excluded. The resulting patients were categorized based on final diagnosis. The pseudotumor cerebri syndrome (PTCS) group included patients with IIH (true IIH or medication-related). The PTCS vs. non-PTCS groups were analyzed for differences in presentation. For the non-PTCS group, the Diagnosis Error Evaluation and Research (DEER) taxonomy tool was applied.

Of 54 patients with suspected IIH, 34 had IIH and 8 had pseudotumor cerebri due to a medication (PTCS group; 78%). The remaining 12 patients (22%) had alternate diagnoses(non-PTCS group): craniosynostosis (2), malignancy (3), benign tumor (1), hydrocephalus (1), retinitis pigmentosa (1), and inflammatory/infectious etiologies (4). Statistically significant differences between the PTCS and non-PTCS groups included age at presentation (average age 11.9 [CI 10.5-13.2] vs. 8.8 [CI 6.9-9.7]), full fields at presentation (35% [CI 23%-46%] vs. 10% [CI 0%-23%]), BMI (23.8 [CI 21.7-25.9] vs. 17.5 [CI 15.7-21.5]), change in RNFL from presentation to follow up (decrease of 28% [CI -19% to -37%] vs. 45% [CI -40% to -50%]), and ventriculomegaly on MRI (7% [CI 3%-11%] vs. 33% [CI 17%-48%]). The DEER tool revealed the greatest number of cases (8) had errors involving laboratory/radiology testing.

Even for patients referred specifically for suspected IIH, it is important to remember alternate diagnoses and complete a thorough workup. Early imaging and attention to findings that are atypical for IIH are important in reaching a correct diagnosis.
Authors/Disclosures
Melissa Yuan
PRESENTER
Ms. Yuan has nothing to disclose.
Ethan Zhao Mr. Zhao has nothing to disclose.
No disclosure on file
No disclosure on file
Cristiano Oliveira, MD (Weill Cornell Medical College) Dr. Oliveira has nothing to disclose.
Marc Dinkin, MD (Weill Cornell Neurology and Ophthalmology) Dr. Dinkin has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for WILSON ELSER MOSKOWITZ EDELMAN & DICKER LLP. Dr. Dinkin has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Rehabilitation Alternative Services, Inc.. Dr. Dinkin has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for AMFS / Medical Experts Nationwide. Dr. Dinkin has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Bekman, Marder, Hopper, Malarkey & Perlin, L.L.C.. Dr. Dinkin has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Northwestern Mutual. Dr. Dinkin has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Young Conaway Stargatt & Taylor. Dr. Dinkin has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Young and Conway . Dr. Dinkin has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Luks, Santiello.